Skip to main content
. 2018 Dec 3;13(12):e0208225. doi: 10.1371/journal.pone.0208225

Fig 1. Serum IP-10 levels, DPPIV activity and BA levels in HCV patients (n = 229).

Fig 1

A) Cholestatic HCV patients with serum BA > 10μM had higher IP-10 serum levels. Mean ± SD (Wilcoxon Mann Whitney test; ** = p<0.01). B) Positive correlation between IP-10 serum levels and DPPIV serum activity (Pearson-Rho 0.25; p<0.01). C) Cholestatic HCV patients had higher DPPIV serum activity. Mean ± SD (Wilcoxon Mann Whitney test; *** = p<0.001). D) Non-SVR patients had higher IP-10 levels (E), higher DPPIV serum activity (F) and a trend towards higher serum BA compared to HC. Mean ± SD (Wilcoxon Mann Whitney test; ** = p < 0.01).